Frazier Life Sciences Management L.P. grew its holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 0.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,764,232 shares of the company’s stock after buying an additional 80,000 shares during […]
Frazier Life Sciences Management L.P. grew its holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 0.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,764,232 shares of the company’s stock after buying an additional 80,000 shares during […]
Appian Way Asset Management LP lifted its stake in shares of Dycom Industries, Inc. (NYSE:DY – Free Report) by 116.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 107,166 shares of the construction company’s stock after buying an additional 57,627 shares during the […]
Wasatch Advisors LP raised its holdings in Clearwater Analytics Holdings, Inc. (NYSE:CWAN – Free Report) by 17.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 12,087,022 shares of the company’s stock after purchasing an additional 1,831,571 shares during the quarter. Clearwater Analytics […]
Avidity Partners Management LP grew its holdings in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 55.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 844,500 shares of the biopharmaceutical company’s stock after acquiring an additional 300,500 shares during the period. […]